Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
Código da empresaSEER
Nome da EmpresaSeer Inc
Data de listagemDec 04, 2020
CEOFarokhzad (Omid C)
Número de funcionários134
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 04
Endereço3800 Bridge Parkway, Suite 102
CidadeREDWOOD CITY
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94065
Telefone16504530000
Sitehttps://seer.bio/
Código da empresaSEER
Data de listagemDec 04, 2020
CEOFarokhzad (Omid C)
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados